For older adults, the flu vaccine could look a little different this year.
The Food and Drug Administration has approved a new flu vaccine made with the same mRNA technology that was used for the COVID-19 shots.
The shot, made by Moderna, will be available for this year's upcoming flu season.
The FDA’s approval is welcome news, and will hopefully open the door to much faster production of an effective vaccine to ...
The Food and Drug Administration has approved the first-ever mRNA flu vaccine, a shot that will use new technology to target ...
A new mRNA flu vaccine showed a 27% reduction in flu cases in a clinical trial, but its path to FDA approval faced an early ...
Moderna received FDA approval for its new mRNA-based flu shot for older adults after months of regulatory questioning.
Researchers found the shot to be about 27% more effective than the standard flu shot ...
The approval of Moderna’s new flu vaccine comes months after the FDA faced backlash for refusing to review the shot.
The U.S. Food and Drug Administration has approved a new mRNA-based seasonal flu vaccine for people 50 and older, Moderna ...
The US Food and Drug Administration on Wednesday approved the United States’ first mRNA-based flu vaccine for adults 50 and ...
Vaccine makers can produce mRNA shots faster than those made with older technology, which could cut the risk of a mismatch ...